Heathcare Treasure

Connected drug delivery devices are transforming the way patients receive medication. These devices combine drug delivery technology with connectivity to the internet and other devices, enabling healthcare providers to monitor and manage patients remotely. By improving patient adherence to medication and reducing the risk of errors, connected drug delivery devices are improving patient outcomes and reducing healthcare costs. Connected Drug Delivery Devices Overview and Products Types Connected drug delivery devices come in a variety of forms, from inhalers and injectors to pumps and patches. These devices are designed to provide patients with the correct dose of medication at the right time, while also allowing healthcare providers to monitor and manage patient adherence to their medication regimen. Some of the key players in the connected drug delivery devices market include BD, West Pharmaceutical Services, and Gerresheimer. Connected Drug Delivery Devices Market Dynamics The global

Rett syndrome is a rare genetic disorder that affects primarily females, with a reported incidence rate of approximately 1 in 10,000 to 15,000 live female births. This disorder affects the development of the brain and leads to severe intellectual and physical disability. Until recently, there were no approved treatments for Rett syndrome, but that has changed with the introduction of DAYBUE. Rett Syndrome Treatment Landscape The Rett syndrome treatment landscape has been limited, with few available options for patients. Most treatments have focused on symptom management, rather than addressing the underlying cause of the disorder. These treatments include physical therapy, speech therapy, and medication to manage seizures and other symptoms. Approval of DAYBUE: A Long-awaited Hope for Rett Syndrome Patients DAYBUE is the first and only approved drug for Rett syndrome treatment. The drug was approved by the FDA in August 2021, following promising clinical trial results. DAYBUE works b